Nevada Medicaid and Nevada Check Up News (Third Quarter 2025 Provider Newsletter) [Read]

Attention Behavioral Health Providers: Monthly Behavioral Health Training Assistance (BHTA) Webinar Scheduled [See Web Announcement 2009]

Attention All Providers: Requirements on When to Use the National Provider Identifier (NPI) of an Ordering, Prescribing or Referring (OPR) Provider on Claims [Announcement 850]

If you are a Medicaid provider whose revalidation application has not been processed by your termination due date, you will be ineligible to provide services to any Nevada Medicaid or Nevada Check Up recipients, including both Fee-for-Service and Managed Care Organization (MCO) enrolled recipients. See Web Announcement 1265

Enrollment Termination Frequently Asked Questions (FAQs) [Review]

Featured Links

DHCFP EVV

Authorization Criteria

DHCFP Home

EDI Information

PWP User Manual

Provider Enrollment

Provider Login (PWP)

Prior Authorization

Search Fee Schedule

Search Providers

Claims

Trading Partner

Self-Paced Training Videos

Notifications

Provider Flex is now LIVE for all provider types!
For information and training opportunities on this exciting new enrollment tool, please visit our Provider Flex page

Multi-Factor Authentication Frequently Asked Questions

Known System Issues-Click HERE

Top 10 Claim Denial Reasons and Resolutions/Workarounds for November 2025 Professional Claims. See Web Announcement 3789.

Top Prior Authorization Denial Reasons for the Third Quarter of 2025. See Web Announcement 3758.

Attention Providers Using the Authorization Criteria Function: Results that return prior authorization (PA) requirements are accurate. For results that return “There are no records found based on the search criteria,” there may be a PA requirement if limits have been exceeded. To verify PA requirements, please refer to the Medicaid Services Manual (MSM) Chapter for your service type at dhcfp.nv.gov and the Billing Guide for your provider type at www.medicaid.nv.gov.

Provider Links

DHCFP EVV

Billing Information

Forms

Provider Enrollment

Provider Newsletters

Provider Training

Scheduled Site Maintenance

During the scheduled site maintenance window the Provider Web Portal will be unavailable. The table below shows the regularly scheduled maintenance window. All times will be in the Pacific time zone.

Monday - Friday
12:00AM - 12:30AM

Monday
8:00PM - 12:00AM

Enhance your search:
  • Note that you can use "*" and "?" as wildcards.

  • Enclosing more than one word in double quotes ("search engine") will search for the exact phrase.
Example Zoom search template page

Search this site

Enter one or more keywords to search for using the Zoom Search Engine.
Note that '*' and '?' wildcards are supported.



Match:

Search results for: wa 0821 7001 0763 fortress pintu baja fortress double sanankulon blitar

No results found containing all search terms. 590 results found containing some search terms.

59 pages of results.
Sort by relevance / Sorted by date ▼
1. Known_Issues.pdf
... L1851-(Knee needed. Once resolved, claims will be orthosis KO, double upright, thigh and calf, with automatically reprocessed. adjustable flexion and extension ...
Terms matched: 1  -  Score: 11  -  26 Nov 2025  -  URL: https://www.medicaid.nv.gov/Downloads/provider/Known_Issues.pdf
2. web_announcement_3560_20250220.pdf
... provider website For more information about PT 93, see the following web announcements (WA): • WA 3383 • WA 3452 †...
Terms matched: 1  -  Score: 124  -  20 Feb 2025  -  URL: https://www.medicaid.nv.gov/Downloads/provider/web_announcement_3560_20250220.pdf
3. Inhaled Anticholinergics.pdf
... patients and two confirmatory trials. The two confirmatory trials were replicate, randomized, double- blind, active controlled, parallel group trials. They evaluated 1, ...
Terms matched: 1  -  Score: 12  -  28 Sep 2024  -  URL: https://www.medicaid.nv.gov/Downloads/provider/Inhaled%20Anticholinergics.pdf
4. Incretin_Mimetics_Amylinomimetics_2018-06.pdf
... prespecified secondary analysis found that the composite renal outcome (new-onset persistent macroalbumineria, persistent doubling of serum creatinine level, end-stage renal disease, and death due to renal ...
Terms matched: 1  -  Score: 12  -  28 Sep 2024  -  URL: https://www.medicaid.nv.gov/Downloads/provider/Incretin_Mimetics_Amylinomimetics_2018-06.pdf
5. Incretin_Mimetics_2013-1031.pdf
... diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double- blind, placebo-controlled trials. Clin Ther. 2007;29(1 ...
Terms matched: 1  -  Score: 10  -  28 Sep 2024  -  URL: https://www.medicaid.nv.gov/Downloads/provider/Incretin_Mimetics_2013-1031.pdf
6. Incretin_Mimetics_2013-0812.pdf
... diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double- blind, placebo-controlled trials. Clin Ther. 2007;29(1 ...
Terms matched: 1  -  Score: 10  -  28 Sep 2024  -  URL: https://www.medicaid.nv.gov/Downloads/provider/Incretin_Mimetics_2013-0812.pdf
7. Incretin_Mimetics _Amylinomimetics_2018-09.pdf
... prespecified secondary analysis found that the composite renal outcome (new-onset persistent macroalbumineria, persistent doubling of serum creatinine level, end-stage renal disease, and death due to renal ...
Terms matched: 1  -  Score: 12  -  28 Sep 2024  -  URL: https://www.medicaid.nv.gov/Downloads/provider/Incretin_Mimetics%20_Amylinomimetics_2018-09.pdf
8. Incretin Mimetics.pdf
... diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double- blind, placebo-controlled trials. Clin Ther. 2007;29(1 ...
Terms matched: 1  -  Score: 10  -  28 Sep 2024  -  URL: https://www.medicaid.nv.gov/Downloads/provider/Incretin%20Mimetics.pdf
9. Immunomodulators_2018-0910.pdf
... (SQ) formulation of Orencia (abatacept) was based on a double-blind, double- dummy, randomized trial demonstrating noninferiority to the intravenous (IV) formulation ...
Terms matched: 1  -  Score: 46  -  28 Sep 2024  -  URL: https://www.medicaid.nv.gov/Downloads/provider/Immunomodulators_2018-0910.pdf
10. Immunomodulators_2018-09.pdf
... (SQ) formulation of Orencia (abatacept) was based on a double-blind, double- dummy, randomized trial demonstrating noninferiority to the intravenous (IV) formulation ...
Terms matched: 1  -  Score: 46  -  28 Sep 2024  -  URL: https://www.medicaid.nv.gov/Downloads/provider/Immunomodulators_2018-09.pdf
Result Pages: 1 2 3 4 5 6 7 8 9 10 11 Next >>

Search powered by Zoom Search Engine



Search took 0.063 seconds